| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 09/15/2005 | WO2005049589A3 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases |
| 09/15/2005 | WO2005046578A3 Isoquinolinone potassium channel inhibitors |
| 09/15/2005 | WO2005039496A3 Inhibitors of cathepsin s |
| 09/15/2005 | WO2004096792A3 Novel indole derivatives, method of preparing same in the form of medicaments, pharmaceutical compositions and, in particular, kdr inhibitors |
| 09/15/2005 | WO2004091514A3 Cgrp receptor antagonists |
| 09/15/2005 | US20050203294 Process for the preparation of benazepril hydrochloride |
| 09/15/2005 | US20050203173 PI-3 kinase inhibitor prodrugs |
| 09/15/2005 | US20050203170 Chalcones substitued with amine or amino acid-derived amide, specifically (S)-2-amino-3-hydroxypropanoic acid (2-methoxy-5-[2-methyl-3-oxo-3-(3,4,5-trimethoxyphenyl)propenyl]phenyl)amide hydrochloride; use inhibiting tubulin polymerization; antitumor agents |
| 09/15/2005 | US20050203159 Calcium channel modulators 2-(alkyl or (hetero)arylalkylthio)-imidazoles and S-oxides thereof; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 09/15/2005 | US20050203155 Imidazole compounds and human cellular proteins casein kinase I alpha, delta and epsilon as targets for medical intervention against Hepatitis C Virus infections |
| 09/15/2005 | US20050203146 P2Y1 Purinoreceptor; thromboembolic disorders; compounds are 2-((hetero)arylamino) benzimidazoles, benzoxazoles or benzothiazoles such as [2-(2-tert-butyl-phenoxy)-pyridin-3-yl]-(6-methyl-1H-benzoimidazol-2-yl)-amine |
| 09/15/2005 | US20050203145 Chronic inflammation, rheumatoid arthritis, colitis, asthma and psoriasis; solid phase synthetic methods to efficiently construct numerous drug-like libraries |
| 09/15/2005 | US20050203144 Use against multi-drug resistant staphylococci, streptococci, enterococci, Bacteroides, Clostridia, Mycobacterium tuberculosis; e.g. N-[5(S)-3-[3,5-Difluoro-4-[(1alpha,5alpha,6alpha )-6-[(2-(1,3-dihydroxy)propyloxy)iminomethyl]-3-azabicyclo[3.1.0]hexan-3-yl]phenyl]-2-oxooxazolidin-5-ylmethyl]acetamide |
| 09/15/2005 | US20050203140 Paroxetine base, 1-methyl-3-hydroxymethyl-4-(4'-fluorophenyl)piperidine and paroxetine hydrochloride; chemical intermediates |
| 09/15/2005 | US20050203138 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/15/2005 | US20050203128 Antiinflammatory agents; antiallergens; antiproliferative agents; 4-(5-Fluoro-2-hydroxy-phenyl)-2-hydroxy-4-methyl-2-trifluoromethyl-pentanoic acid (3,5-dichloro-phenyl)-amide |
| 09/15/2005 | US20050203119 Dihydropyridine compounds for treating or preventing metabolic disorders |
| 09/15/2005 | US20050203112 Bicyclic amides |
| 09/15/2005 | US20050203104 Cycloalkyl - containing 5-acylindolinones, the preparation thereof and their use as medicaments |
| 09/15/2005 | US20050203101 Benzimidazole quinolinones and uses thereof |
| 09/15/2005 | US20050203094 Thromboembolic disorders; anticoagulants; e.g. 2-[5'-fluoro-2,2'-dihydroxy-5-(2-oxo-tetrahydro-furan-3-yl)-biphenyl-3-yl]-1H-benzoimidazole-5-carboxamidine |
| 09/15/2005 | US20050203093 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/15/2005 | US20050203092 4-Pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 09/15/2005 | US20050203083 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; e.g. Biphenyl-2-ylcarbamic acid 1-(2-[5-(4-hydroxybenzylamino)pentylcarbamoyl]ethyl)piperidin-4-yl ester; long duration of action; reduced side effects, such as dry-mouth and constipation |
| 09/15/2005 | US20050201939 Dye-peptide complex; supplying to tumor cells; for diagnostic imaging and therapy; biocompatibility |
| 09/15/2005 | CA2558600A1 A substituted-trialkyl amine compound with anti-viral activity based on antagonism against a chemokine receptor cxcr4 |
| 09/15/2005 | CA2558278A1 Diaryl-substituted five-membered heterocycle derivative |
| 09/15/2005 | CA2557858A1 Amino cyclopropane carboxamide derivatives as bradykinin antagonists |
| 09/15/2005 | CA2557645A1 Caspase inhibitors and uses thereof |
| 09/15/2005 | CA2557322A1 Inhibitors of hepatitis c virus ns3 protease |
| 09/15/2005 | CA2556387A1 Bicyclic anthranilamide derivatives useful as insecticides |
| 09/15/2005 | CA2555712A1 Novel cyclic compound having 4-pyridylalkylthio group having substituted or unsubstituted amino group introduced therein |
| 09/14/2005 | EP1574510A1 Substituted pyridine herbicides |
| 09/14/2005 | EP1572691A1 Pyrazole compounds as integrin receptor antagonists derivatives |
| 09/14/2005 | EP1572686A1 Anthranilic acid amide derivatives and their pharmaceutical use |
| 09/14/2005 | EP1572685A1 Substituted benzodioxepins |
| 09/14/2005 | EP1572670A1 5-substituted-pyrazine or -pyridine glucokinase activators |
| 09/14/2005 | EP1572668A2 N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines |
| 09/14/2005 | EP1572667A1 Cathepsin cysteine protease inhibitors and their use |
| 09/14/2005 | EP1572664A1 Pyrazole compounds |
| 09/14/2005 | EP1572662A1 Pyrazole and imidazole compounds and uses thereof |
| 09/14/2005 | EP1572660A1 Isoquinolinone derivatives and their use as therapeutic agents |
| 09/14/2005 | EP1572653A1 Saturated and unsaturated heteroarylcycloalkylmethyl amines as anti-depressants |
| 09/14/2005 | EP1572650A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 09/14/2005 | EP1572648A1 3,6-disubstituted azabicyclo (3.1.0)-hexane derivatives as muscarinic receptor antagonists |
| 09/14/2005 | EP1572646A1 N-(indolethyl-)cacloamine compounds |
| 09/14/2005 | EP1572642A1 3-pyrrolyl urea derivatives and their use as antiviral agents |
| 09/14/2005 | EP1572638A2 An improved process for the preparation of amorphous atorvastatin calcium salt (2:1) |
| 09/14/2005 | EP1572628A1 Isophtalic acid derivatives |
| 09/14/2005 | EP1572239A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia |
| 09/14/2005 | EP1572215A1 Benzo[d]azepine derivatives for the treatment of neurological disorders |
| 09/14/2005 | EP1572209A1 Novel quinoxalinone derivatives as bradykinin b1 antagonists |
| 09/14/2005 | EP1572207A1 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines |
| 09/14/2005 | EP1572200A1 Aminoindazole derivatives and use thereof as kinase inhibitors |
| 09/14/2005 | EP1572199A2 Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity |
| 09/14/2005 | EP1499609A4 Pesticidal heterocycles |
| 09/14/2005 | EP1385834B1 Bicyclo[3,1,0]hexane containing oxazolidinone antibiotic and derivatives thereof |
| 09/14/2005 | EP1289954B1 Serine protease inhibitors |
| 09/14/2005 | EP1283825B1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 09/14/2005 | EP1210335B1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments |
| 09/14/2005 | CN1668615A Novel benzimidazole derivatives |
| 09/14/2005 | CN1668613A Flavone derivatives of inhibitors of cyclin-dependent kinases |
| 09/14/2005 | CN1668603A Pyridazin-3(2h)-one derivatives as PDE4 inhibitors |
| 09/14/2005 | CN1668602A 6-amino-1H-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
| 09/14/2005 | CN1668601A N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors |
| 09/14/2005 | CN1668589A Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments |
| 09/14/2005 | CN1668585A 3, 6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 09/14/2005 | CN1668584A Pyrrole derivatives as antimycobacterial compounds |
| 09/14/2005 | CN1668300A Spirocyclic piperidines as MCH1 antagonists and uses thereof |
| 09/14/2005 | CN1668299A Methods for using JNK inhibitors for treating or preventing disease-related wasting |
| 09/14/2005 | CN1666983A Substituted aminoquinazolinone (thione) derivatives or salts thereof, intermediates thereof, and pest contollers and a method for using the same |
| 09/13/2005 | US6943249 recrystallizing from a polar aprotic solvent (dimethylsulfoxide, dimethylformamide, dimethylacetamide, or N-methylpyrrolidinone) and a cosolvent (acetonitrile, ethanol, methylethyl ketone, isopropyl alcohol, or 1-propanol); myelodysplastic syndrome |
| 09/13/2005 | US6943186 Administering benzopyrazolyl compound for therapy of sepsis |
| 09/13/2005 | US6943183 Antiproliferative agnets; anticancer agents; skin disorders; restenosis |
| 09/13/2005 | US6943182 Cyclopentabenzofuran derivatives and their use |
| 09/13/2005 | US6943169 Quinolinone derivatives and uses thereof |
| 09/13/2005 | US6943161 For prophylaxis and therapy of inflammation, asthma, arthritis, diabetes, atherosclerosis, ocular diseases, restenosis, autoimmune responses, multiple sclerosis, psoriasis, human cancers, fibrosis of liver, lung and kidney |
| 09/13/2005 | CA2426703C Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 09/13/2005 | CA2371587C Piperidine derivatives useful as ccr5 antagonists |
| 09/13/2005 | CA2371583C Piperazine derivatives useful as ccr5 antagonists |
| 09/13/2005 | CA2358724C New cyclobutene-dione derivatives, their method of preparation and pharmaceutical compositions containing them |
| 09/13/2005 | CA2292927C New imidazolin compounds, the process for preparing them and the pharmaceutical compositions that contain them |
| 09/13/2005 | CA2231105C Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives |
| 09/13/2005 | CA2216099C Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase |
| 09/13/2005 | CA2210022C Paroxetine hydrochloride solvates |
| 09/09/2005 | WO2005082892A2 Triazole compounds as antibacterial agents and pharmaceutical compositions containing them |
| 09/09/2005 | WO2005082889A1 Piperidinyl targeting compounds that selectively bind integrins |
| 09/09/2005 | WO2005082884A2 2-pyridin-2yl-pyrimidine derivatives useful in the treatment of gastro-esophagea l reflux disease |
| 09/09/2005 | WO2005082882A1 Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases |
| 09/09/2005 | WO2005082866A2 Substituted 1, 2, 4- triazole derivatives as oxytocin antagonists |
| 09/09/2005 | WO2005082864A1 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors |
| 09/09/2005 | WO2005082863A2 1,4 diaryl-dihydropyrimidin-2 ones and their use as a human neutrophil elastase inhibitors |
| 09/09/2005 | WO2005082859A1 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 09/09/2005 | WO2005082841A1 Immunosuppressant compounds and compositions |
| 09/09/2005 | WO2005082367A1 Kinase inhibitors |
| 09/09/2005 | WO2005058885A3 Piperidine derivatives and their use as glycine transporter inhibitors |
| 09/09/2005 | WO2005046603A3 Pyridine compounds |
| 09/09/2005 | WO2005044192A3 Triazole compounds and uses related thereto |
| 09/09/2005 | WO2005032493A3 Amide compounds as ion channel ligands and uses thereof |
| 09/09/2005 | WO2005030151A3 Compounds and compositions as protein kinase inhibitors |